NOVA EYE MEDICAL LTD

Nova Eye Medical (EYE.AX) jumps 6.9% as investors back its glaucoma tech, boosting the ASX medical‑device sector and showing strong growth potential.

Nova Eye Medical’s shares jump 3.6% as its glaucoma tech gains momentum—small cap, high growth potential, and a solid 200‑day SMA support level.

Nova Eye Medical’s 3.7 % lift looks good on paper, but its weak fundamentals, low liquidity, and stagnant pipeline suggest caution for investors eyeing small‑cap gains.